Vyriad

Vyriad is a clinical-stage company dedicated to developing proprietary oncolytic virus therapies for the treatment of cancer. Vyriad's potentially life-changing oncolytic virus technology is the result of decades of research by dozens of researchers and clinicians from the Mayo Clinic and the University of Miami.